Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3

Gynecologic Oncology

Volumn 103, Issue 2, 2006, Pages 631-636

  Alonso, Immaculada ^a   Torné, Aureli ^a   Puig Tintoré, Luis M ^a   Esteve, Roser ^a   Quinto, Llorenç ^a   Campo, Elias ^a   Pahisa, Jaume ^a   Ordi, Jaume ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

CIN2 3; Conization; Follow up; HPV; Residual Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; COLPOSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EARLY CANCER; EARLY DIAGNOSIS; ELECTROSURGERY; EVALUATION AND FOLLOW UP; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ONSET AGE; PREDICTION; PREDICTION AND FORECASTING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SAMPLE SIZE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX CYTOLOGY; UTERUS BIOPSY; VIRUS DETECTION; VIRUS LOAD; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONIZATION; ELECTROSURGERY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

EID: 33750154460     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.04.016     Document Type: Article

References (36)

1. Pinto A.V., and Crum C.P. Natural history of cervical neoplasia: defining progression and its consequences. Clin Obstet Gynecol 43 (2000) 352-362
2. Paraskevaidis E., Koliopoulos G., Alamanos Y., Malamou-Mitsi V., Lolis E.D., and Kitchener H.C. Human papillomavirus testing and the outcome of treatment for cervical intraepithelial neoplasia. Obstet Gynecol 98 (2001) 833-836
3. Mitchell M.F., Tortolero-Luna G., Cook E., Whittaker L., Rhodes-Morris H., and Silva E. A randomized clinical trial of cryotherapy, laser vaporization and loop electrosurgical excision for treatment of squamous intra-epithelial lesions of the cervix. Obstet Gynecol 92 (1998) 737-744
4. Holowaty P., Miller A.B., Rohan T., and To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 91 (1999) 252-258
5. Nuovo J., Melnikow J., Willan A.R., and Chan B.K. Treatment outcomes for squamous intraepithelial lesions. Int J Gynaecol Obstet 68 (2000) 25-33
6. Zielinski G.D., Bais A.G., Helmerhorst T.J., Verheijen R.H., de Schipper F.A., Snijders P.J.F., et al. HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis. Obstet Gynecol Surv 59 (2004) 543-553
7. Chao A., Lin C.T., Hsueh S., Chou H.H., Chang T.C., Chen M.Y., et al. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization. Am J Obstet Gynecol 190 (2004) 1046-1051
8. Jain S., Tseng C.J., Horng S.G., Soong Y.K., and Pao C.C. Negative predictive value of human papillomavirus test following conization of the cervix uteri. Gynecol Oncol 82 (2001) 177-180
9. Lin C.T., Tseng C.J., Lai C.H., et al. Value of human papillomavirus deoxyribonucleic acid test after conization in the prediction of residual disease in the subsequent hysterectomy specimen. Am J Obstet Gynecol 184 (2001) 940-945
10. Houfflin D.V., Collinet P., Vinatier D., et al. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions. Gynecol Oncol 90 (2003) 587-592
11. Reich O., Pickel H., Lahousen M., Tamussino K., and Winter R. Cervical intraepithelial neoplasia III: long-term outcome after cold-knife conization with clear margins. Obstet Gynecol 97 (2001) 429-430
12. Skjeldestad F.E., Hagen B., Lie A.K., and Isaksen C. Residual and recurrent disease after laser conization for cervical intraepithelial neoplasia. Obstet Gynecol 90 (1997) 428-433
13. Sarian L.O., Derchain S.F., Pittal Dda R., Morais S.S., and Rabelo-Santos S.H. Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ). J Clin Virol 31 (2004) 270-274
14. Bigrigg A., Haffenden D.K., Sheehan A.L., Codling B.W., and Read M.D. Efficacy and safety of large loop excision of the transformation zone. Lancet 343 (1994) 32-34
15. Gardeil F., Barry-Walsh C., Prendville W., et al. Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III. Obstet Gynecol 89 (1997) 419-422
16. Benchimol Y., Mergui J.L., and Uzan S. The role of viral HPV testing in post-operative follow-up. HPV handbook. Current evidence-based applications (2005), Taylor and Francis, New York
17. Nobbenhuis M., Meijer C., van den Brule A., Rozendaal L., Voorhorst F., Risse E., et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 84 (2001) 796-801
18. Bollen L.J., Tjong-A-Hung S.P., and van der Velden J. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology. Gynecol Oncol 72 (1999) 199-201
19. Bar-Am A., Gamzu R., Levin I., Fainaru O., Niv J., and Almog B. Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up. Gynecol Oncol 91 (2003) 149-153
20. Nagai Y., Maehama T., Asato T., and Kanazawa K. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?. Gynecol Oncol 79 (2000) 294-299
21. Acladious N.N., Sutton C., Mandal D., Hopkins R., Zaklama M., and Kitchener H. Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN). Int J Cancer 98 (2002) 435-439
22. Zielinski G.D., Rozendaal L., Voorhost F.J., Berkhof J., Snijders P., Risse E.J., et al. HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3. Gynecol Oncol 91 (2003) 67-73
23. Costa S., de Simone P., Venturoli S., Cricca M., Zerbini M.L., Musiani M., et al. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia grade 3. Gynecol Oncol 90 (2003) 356-358
24. Ordi J., Puig-Tintore L.M., Torne A., Sanz S., Esteve R., Romagosa C., et al. Contribution of high risk human papillomavirus testing to the management of premalignant and malignant lesions of the uterine cervix. Med Clin (Barc) 121 (2003) 441-445
25. Josefsson A.M., Magnusson P.K., Ylitalo N., Sorensen P., Qwarforth-Tubbin P., Andersen P.K., et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355 (2000) 2189-2193
26. Ylitalo N., Sorensen P., Josefsson A.M., Magnusson P.K., Andersen P.K., Ponten J., et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355 (2000) 2194-2198
27. van Duin M., Snijders P.J., Schrijnemakers H.F., Voorhorst F.J., Rozendaal L., Nobbenhuis M.A., et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer 98 (2004) 590-595
28. Clavel C., Cucherousset J., Lorenzato M., Caudroy S., Nou J.M., Nazeyrollas P., et al. Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions. Br J Cancer 90 (2004) 1803-1808
29. Clavel C., Masure M., Bory J.P., Putaud I., Mangeonjean C., Lorenzato M., et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 84 (2001) 1616-1623
30. Solomon D., Davey D., Kurman R., et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 124 (2001) 2114-2119
31. Ordi J., Alonso I., Torné A., Esteve R., Sierra E., Campo E., et al. Human papillomavirus load in hybrid capture 2 assay: does increasing the cutoff improve the test?. Gynecol Oncol 99 (2005) 313-319
32. Hernádi Z., Szoke K., Sapy T., Krasznai Z.T., Soos G., Veress G., et al. Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions. Eur J Obstet Gynecol 118 (2005) 229-234
33. Almog B., Gamzu R., Bornstein L., Levin I., Fainaru O., Niv J., et al. Clinical and economic benefit of HPV-load testing in follow-up and management of women post cone biopsy for CIN2-3. Br J Cancer 89 (2003) 109-112
34. Lillo F.B., Lodini S., Ferrari D., Stayton C., Taccagni G., Galli L., et al. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection. Clin Infect Dis 40 (2005) 451-457
35. Sherman M.E., Wang S.S., Wheeler C.M., Rich L., Gravitt P.E., Tarone R., et al. Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions. Cancer Epidemiol Biomark Prev 12 (2003) 1038-1044
36. Chua K.L., and Hjerpe A. Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri. Gynecol Oncol 66 (1997) 108-113